Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study

Publication Type:

Journal Article

Source:

Lancet Infect Dis, Volume 17, Issue 2, p.215-222 (2017)
Top